Scratching the Itch of Pruritus With Adam Friedman, MD
DERM 2025 featured tips and tricks for a thorough pruritus diagnosis and treatment strategy from Adam Friedman, MD.
Expanding Treatment Options to Pediatric Populations: A Conversation With Lisa Swanson, MD, at DERM 2025
Lisa Swanson, MD, discusses the unmet needs in pediatric dermatology at the DERM 2025 conference.
Forever Chemicals: Michelle Hure, MD, Discusses Clinical Concerns About PFAS in Dermatology
Hure details what clinicians need to know to protect their patients.
New Poster: Systemic Treatment Signals Better Control in Atopic Dermatitis
Joe Gorelick, MSN, FNP-C, discusses data on systemic treatments for atopic dermatitis presented at the Derm 2025 conference.
Clinical Pearls, Practical Approaches, and New Perspectives: Highlights From the First Days of DERM 2025
The DERM 2025 midway recap includes tips for atopic dermatitis, chronic hand eczema, and pruritus.
A Rheum With a View at DERM 2025: Looking at Cutaneous Lupus
Rheumatologist Karim Ladak, MD, shared diagnostic and treatment tips for cutaneous lupus at DERM 2025.
Poster Presented at DERM 2025: High Impact Areas See Positive Results in Icotrokinra Phase 3 Trial
Psoriasis in high impact areas responded well to icotrokinra, presenting a potential exciting option for patients.
Rethinking “Monotherapy Brain” in Complex Skin Disease
At the DERM 2025 conference, Scott Boswell, MD, shares tips for combining therapies.
UnlIMMited Data Demonstrate Risankizumab Efficacy in Genital and Scalp Psoriasis
James Song, MD, discussed his UnlIMMited DERM 2025 poster detailing risankizumab's efficacy for genital and scalp psoriasis.
Conference Brings Leading Experts to Share Practical Pearls
Joe Gorelick, MSN, FNP-C, discusses upcoming highlights and new data expected at the upcoming DERM 2025 CME Conference.
